I am interested in using mathematical models to inform decisions on vaccination policies on meningitis in the African meningitis belt. Currently, my work focuses on figuring the key age group(s) to be targeted on the pentavalent vaccines due to be licenced by the end of 2022 in the African meningitis belt in order to maximize health benefits at a minimum cost.
